Dana-Farber names new CEO: 3 things to know

Boston-based Dana-Farber Cancer Institute has named Laurie H. Glimcher, MD, CEO, effective January 2017, according to The Boston Globe.

Advertisement

Here are three things to know about Dr. Glimcher.

1. Dr. Glimcher, an immunologist, is currently dean of Cornell University’s Weill Cornell Medical College in New York City.

2. She graduated from Harvard Medical School in Boston and later worked as a Harvard professor and physician at Brigham and Women’s Hospital in Boston.

3. In her new role, she will succeed Edward J. Benz Jr., MD, who is retiring.

 

More articles on executive moves:

24 latest hospital, health system executive moves
Comanche County Memorial Hospital CEO retires: 4 things to know
Adventist Health picks new regional CFO for Southern California: 3 things to know

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Executive Moves

Advertisement

Comments are closed.